肝细胞癌患者瘤内γδ T细胞浸润、趋化因子(C-C基序)配体4/趋化因子(C-C基序)配体5蛋白表达与生存
该研究在247例中国肝细胞癌患者中利用γδ T细胞特异性基因标签定量瘤内γδ T细胞,并在美国患者中验证;γδ T细胞标签仅与肿瘤转录组数据相关,与癌旁非肿瘤组织无关,且与NKG2D、颗粒酶、穿孔素及CCL4/CCL5/CCR1/CCR5表达正相关,提示CCL4/CCL5可能招募γδ T细胞至肿瘤区域,增加浸润或增强抗肿瘤免疫并改善预后。
要点
- γδ T细胞特异性基因标签在247例中国肝细胞癌患者中定量,并在美国患者中验证。
- γδ T细胞标签与肿瘤转录组数据相关,癌旁非肿瘤组织无此关联,提示瘤内选择性富集。
- γδ T细胞标签与NKG2D、颗粒酶、穿孔素及CCL4/CCL5/CCR1/CCR5表达正相关。
核心结论
- 作者提出CCL4/CCL5可能与其受体CCR1/CCR5相互作用,可能促进γδ T细胞从外周血或瘤周区域招募至肿瘤区域,瘤内γδ T细胞浸润增加可能增强抗肿瘤免疫并改善患者预后。
研究设计与样本
- 研究利用γδ T细胞特异性基因标签在247例中国肝细胞癌患者中定量γδ T细胞,并在美国肝细胞癌患者中验证该标签。
- 采用182例肝细胞癌患者福尔马林固定石蜡包埋肿瘤活检组织的免疫组化分析验证结果,并在体外及小鼠原位Hepa1-6肝细胞癌模型中验证CCL4/CCL5介导的γδ T细胞招募。
主要发现
- γδ T细胞标签与肿瘤转录组数据相关,而与癌旁非肿瘤转录组数据无此关联,提示γδ T细胞在肿瘤微环境中选择性富集。
- γδ T细胞标签与自然杀伤细胞受体基因NKG2D及细胞溶解性T细胞基因颗粒酶和穿孔素表达正相关,提示更强的T细胞介导的细胞毒活性。
- γδ T细胞特异性基因表达与CCL4/CCL5及γδ T细胞受体CCR1/CCR5表达正相关,免疫组化分析验证了这些结果。
- 体外及小鼠原位Hepa1-6肝细胞癌模型中发现CCL4/CCL5介导γδ T细胞招募的证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is an aggressive malignancy which is often associated with a complex tumor microenvironment attributable to etiology-induced cellular inflammation. γδ T cells are known to detect and react to chronic inflammation, which is linked to cancer development, progression, and metastasis. Our recent genomic study revealed an increased infiltration of several immune cell types, including γδ T cells, in tumor microenvironments of a Thai HCC subtype associated with a good prognosis. APPROACH AND RESULTS: Here, we quantified the amount of γδ T cells using a γδ T-cell-specific gene signature in 247 Chinese HCC patients. We also validated the γδ T-cell signature in American HCC patients. Additionally, such an association was only found in tumor transcriptomic data, but not in adjacent nontumor transcriptomic data, suggesting a selective enrichment of γδ T cells in the tumor microenvironment. Moreover, the γδ T-cell signature was positively correlated with the expression of natural killer cell receptor genes, such as NKG2D and cytolytic T-cell genes granzymes and perforin, suggesting a stronger T-cell-mediated cytotoxic activity. Furthermore, we found that the γδ T-cell-specific gene expression is positively correlated with the expression of chemokine (C-C motif) ligand 4 (CCL4)/chemokine (C-C motif) ligand 5 (CCL5) and C-C chemokine receptor type 1 (CCR1)/C-C chemokine receptor type 5 (CCR5), the receptors for γδ T cells. We validated these results using immunohistochemical analysis of formalin-fixed, paraffin-embedded tumor biopsies from 182 HCC patients. Moreover, we found evidence of CCL4/CCL5-mediated recruitment of γδ T cells both in vitro and in a murine orthotopic Hepa1-6 HCC model. CONCLUSIONS: We propose that CCL4/CCL5 may interact with their receptor, CCR1/CCR5, which may facilitate the recruitment of γδ T cells from peripheral blood or peritumor regions to the tumor regions. Consequently, an increasing infiltration of γδ T cells in tumors may enhance antitumor immunity and improve patients' prognosis.
引用
- Zhao N, Dang H, Ma L, et al. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma. Hepatology. 2021. PMID: 32502310. doi:10.1002/hep.31412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。